NICE and Flatiron partner to utilise real-world oncology data in informing decisions about cancer therapy access

  • Flatiron Health have been partnered with the FDA in the US since 2016, with whom they have explored real-world outcomes and alternative study methods
  • Experts from both NICE and Flatiron Health will conduct research using Flatiron’s electronic health record (EHR)-derived database
  • “We are excited to explore how real-world evidence could be incorporated into our work in the future. Working in this way will test how additional sources of evidence could complement trial and research data in our technology appraisals, especially in helping to resolve uncertainty in the evidence.” – Pall Jonsson, Associate Director for Science Policy and Research, NICE

Click here to learn more

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit www.svmpharma.com and contact us at enquiry@svmpharma.com

ref: AUG2020BR001

Posted in Blogs.